Prasugrel

Circulation - United States
doi 10.1161/circulationaha.109.921502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Current Oral Antiplatelets: Focus Update on Prasugrel

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2012English

Prasugrel Suppresses Development of Lithium-Induced Nephrogenic Diabetes Insipidus in Mice

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2017English

Clinical Outcomes of Patients With ACS Treated With Prasugrel

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2013English

Human Medicines European Public Assessment Report (EPAR): Prasugrel Mylan, Prasugrel, Myocardial Infarction,Acute Coronary Syndrome,Angina, Unstable, Date of Authorisation: 15/05/2018, Revision: 3, Status: Authorised

Case Medical Research
2019English

Morphine Interaction With Prasugrel: A Double-Blind, Cross-Over Trial in Healthy Volunteers

Clinical Research in Cardiology
MedicineCardiovascular MedicineCardiology
2015English

Effects of Prasugrel on Platelet Inhibition During Systemic Endotoxaemia: A Randomized Controlled Trial

Clinical Science
Medicine
2012English

Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel Versus Clopidogrel

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2016English

Pharmacological, Pharmacodynamics, and Clinical Profile of Prasugrel Hydrochloride (Efient® Tablets 3.75 Mg • 5 Mg)

Folia Pharmacologica Japonica
Pharmacology
2014English

Acoustic Studies of Molecular Interactions of Prasugrel-HCl Drug With Methanol at Various Temperatures

International Journal of Advanced Science and Technology
EnergyEngineeringComputer Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy